FORA Capital’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-3,965
Closed -$1.61M 669
2025
Q2
$1.61M Buy
3,965
+1,989
+101% +$832K 0.18% 152
2025
Q1
$983K Buy
+1,976
New +$1.07M 0.1% 231
2024
Q2
Sell
-10,626
Closed -$6.18M 538
2024
Q1
$6.18M Buy
10,626
+542
+5% +$304K 0.51% 57
2023
Q4
$5.35M Sell
10,084
-5,394
-35% -$2.61M 0.46% 67
2023
Q3
$7.83M Buy
15,478
+873
+6% +$465K 0.69% 33
2023
Q2
$7.62M Buy
14,605
+9,839
+206% +$5.31M 1.08% 17
2023
Q1
$2.75M Sell
4,766
-8,121
-63% -$4.58M 0.28% 111
2022
Q4
$7.1M Buy
+12,887
New +$6.83M 1.15% 13
2022
Q3
Sell
-3,647
Closed -$1.98M 573
2022
Q2
$1.98M Buy
3,647
+887
+32% +$488K 0.39% 80
2022
Q1
$1.64M Sell
2,760
-1,997
-42% -$1.15M 0.3% 97
2021
Q4
$3.17M Sell
4,757
-4,222
-47% -$2.64M 1.23% 12
2021
Q3
$5.13M Buy
+8,979
New +$4.93M 1.3% 13
2021
Q2
Sell
-4,046
Closed -$1.85M 1151
2021
Q1
$1.85M Buy
4,046
+3,278
+427% +$1.56M 0.61% 33
2020
Q4
$358K Buy
768
+184
+32% +$86.3K 0.05% 359
2020
Q3
$258K Buy
+584
New +$241K 0.17% 134

Other funds holding TMO

FORA Capital's TMO Position: Q3 2025 in Review

FORA Capital sold out of Thermo Fisher Scientific (TMO) in Q3 2025, closing a stake of 3,965 shares — an estimated $1.61M sold.

FORA Capital first reported a position in TMO in Q3 2020 and held it in 15 quarters. The position peaked at $7.83M in Q3 2023. 2,515 funds tracked by Wall St. Rank hold TMO as of Q3 2025.

  • FORA Capital reported no remaining Thermo Fisher Scientific position as of Q3 2025 after selling out during the quarter.
  • FORA Capital sold 3,965 Thermo Fisher Scientific shares in Q3 2025, an estimated $1.61M.
  • FORA Capital first reported a position in Thermo Fisher Scientific in Q3 2020 and held it in 15 quarters.
  • FORA Capital's Thermo Fisher Scientific position peaked at $7.83M in Q3 2023.
  • 2,515 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2025.

Based on FORA Capital's 13F filing for Q3 2025, filed 13 Nov 2025.